The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F22%3A00013863" target="_blank" >RIV/75010330:_____/22:00013863 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00216208:11110/22:10445464 RIV/00216208:11120/22:43923727 RIV/00064211:_____/22:S0000038

Výsledek na webu

<a href="https://e-coretvasa.cz/artkey/cor-202203-0004_the-power-and-wisdom-of-prevention-cardiovascular-risk-new-challenge-and-approach-to-plwh.php" target="_blank" >https://e-coretvasa.cz/artkey/cor-202203-0004_the-power-and-wisdom-of-prevention-cardiovascular-risk-new-challenge-and-approach-to-plwh.php</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.33678/cor.2021.132" target="_blank" >10.33678/cor.2021.132</a>

Jazyk výsledku

angličtina

Název v původním jazyce

The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH

Popis výsledku v původním jazyce

In recent years, quality of life is one of the important points of discussion among specialists working with people living with HIV (PLWH). With the introduction of highly effective antiretroviral therapy (1996), the expectation of life has dramatically increased and atherosclerotic diseases have become an important cause of morbidity and mortality in people infected with human immunodeficiency virus (HIV). Cardiovascular diseases are the third leading cause of mortality in HIV patients behind non-AIDS-related malignancies and non-AIDS-related infection. One of the many aspects in the treatment of PLWH concerns the prevention of cardiovascular diseases. The absolute risk of developing major cardiovascular disease events (CVD), for example, sudden cardiac death, cardiac arrest, and stroke in HIV-infected patients receiving antiretroviral therapy is still low. However, this risk is increased compared to the risk of uninfected people. This fact is substantially due to a higher prevalence of traditional cardiovascular risk factors that are mostly dependent on the host. Different types of antiretroviral treatment impact differently on metabolic effects and CVD. Prevention of cardiovascular disease in HIV-infected patients is an important goal for a better quality of life. Traditional risk factors should be detected and treated vigorously when possible, to avoid the development of major adverse cardiovascular events (MACE).

Název v anglickém jazyce

The power and wisdom of prevention. Cardiovascular risk, new challenge, and approach to PLWH

Popis výsledku anglicky

In recent years, quality of life is one of the important points of discussion among specialists working with people living with HIV (PLWH). With the introduction of highly effective antiretroviral therapy (1996), the expectation of life has dramatically increased and atherosclerotic diseases have become an important cause of morbidity and mortality in people infected with human immunodeficiency virus (HIV). Cardiovascular diseases are the third leading cause of mortality in HIV patients behind non-AIDS-related malignancies and non-AIDS-related infection. One of the many aspects in the treatment of PLWH concerns the prevention of cardiovascular diseases. The absolute risk of developing major cardiovascular disease events (CVD), for example, sudden cardiac death, cardiac arrest, and stroke in HIV-infected patients receiving antiretroviral therapy is still low. However, this risk is increased compared to the risk of uninfected people. This fact is substantially due to a higher prevalence of traditional cardiovascular risk factors that are mostly dependent on the host. Different types of antiretroviral treatment impact differently on metabolic effects and CVD. Prevention of cardiovascular disease in HIV-infected patients is an important goal for a better quality of life. Traditional risk factors should be detected and treated vigorously when possible, to avoid the development of major adverse cardiovascular events (MACE).

Druh

J_imp - Článek v periodiku v databázi Web of Science

CEP obor

—

OECD FORD obor

30304 - Public and environmental health

Projekt

—

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2022

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Cor et Vasa

ISSN

0010-8650

e-ISSN

1803-7712

Svazek periodika

64

Číslo periodika v rámci svazku

3

Stát vydavatele periodika

CZ - Česká republika

Počet stran výsledku

9

Strana od-do

291-299

Kód UT WoS článku

000826775300005

EID výsledku v databázi Scopus

2-s2.0-85135075663